» Articles » PMID: 37106386

Osteosarcoma Tumors Maintain Intra-tumoral Transcriptional Heterogeneity During Bone and Lung Colonization

Overview
Journal BMC Biol
Publisher Biomed Central
Specialty Biology
Date 2023 Apr 27
PMID 37106386
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Tumors are complex tissues containing collections of phenotypically diverse malignant and nonmalignant cells. We know little of the mechanisms that govern heterogeneity of tumor cells nor of the role heterogeneity plays in overcoming stresses, such as adaptation to different microenvironments. Osteosarcoma is an ideal model for studying these mechanisms-it exhibits widespread inter- and intra-tumoral heterogeneity, predictable patterns of metastasis, and a lack of clear targetable driver mutations. Understanding the processes that facilitate adaptation to primary and metastatic microenvironments could inform the development of therapeutic targeting strategies.

Results: We investigated single-cell RNA-sequencing profiles of 47,977 cells obtained from cell line and patient-derived xenograft models as cells adapted to growth within primary bone and metastatic lung environments. Tumor cells maintained phenotypic heterogeneity as they responded to the selective pressures imposed during bone and lung colonization. Heterogenous subsets of cells defined by distinct transcriptional profiles were maintained within bone- and lung-colonizing tumors, despite high-level selection. One prominent heterogenous feature involving glucose metabolism was clearly validated using immunofluorescence staining. Finally, using concurrent lineage tracing and single-cell transcriptomics, we found that lung colonization enriches for multiple clones with distinct transcriptional profiles that are preserved across cellular generations.

Conclusions: Response to environmental stressors occurs through complex and dynamic phenotypic adaptations. Heterogeneity is maintained, even in conditions that enforce clonal selection. These findings likely reflect the influences of developmental processes promoting diversification of tumor cell subpopulations, which are retained, even in the face of selective pressures.

Citing Articles

is a potential therapeutic target for osteosarcoma: and evaluations using generated artificial osteosarcoma cancer stem cell‑like cells.

Miyamoto T, Fukase N, Kawamoto T, Fujiwara S, Hara H, Sawada R Oncol Rep. 2024; 53(2).

PMID: 39704263 PMC: 11667212. DOI: 10.3892/or.2024.8857.


Metabolic shifts in lipid utilization and reciprocal interactions within the lung metastatic niche of triple-negative breast cancer revealed by spatial multi-omics.

Kan J, Lee H, Hou M, Tsai H, Jian S, Chang C Cell Death Dis. 2024; 15(12):899.

PMID: 39695088 PMC: 11655832. DOI: 10.1038/s41419-024-07205-4.


Immunohistochemical study of histone protein 3 modification in pediatric osteosarcoma identifies reduced H3K27me3 as a marker of poor treatment response.

Kondratowski S, Cohen D, Deyell R, Sandhu A, Bush J PLoS One. 2024; 19(11):e0309471.

PMID: 39570878 PMC: 11581320. DOI: 10.1371/journal.pone.0309471.


Integrated single-cell analysis reveals heterogeneity and therapeutic insights in osteosarcoma.

He D, Che X, Zhang H, Guo J, Cai L, Li J Discov Oncol. 2024; 15(1):669.

PMID: 39556142 PMC: 11573940. DOI: 10.1007/s12672-024-01523-x.


Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma.

Ringwalt E, Currier M, Glaspell A, Chen C, Cannon M, Cam M Mol Ther Oncol. 2024; 32(4):200886.

PMID: 39492947 PMC: 11530761. DOI: 10.1016/j.omton.2024.200886.


References
1.
Sun X, Yu Q . Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment. Acta Pharmacol Sin. 2015; 36(10):1219-27. PMC: 4648179. DOI: 10.1038/aps.2015.92. View

2.
Casali P, Bielack S, Abecassis N, Aro H, Bauer S, Biagini R . Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; 29(Suppl 4):iv79-iv95. DOI: 10.1093/annonc/mdy310. View

3.
Marusyk A, Polyak K . Tumor heterogeneity: causes and consequences. Biochim Biophys Acta. 2009; 1805(1):105-17. PMC: 2814927. DOI: 10.1016/j.bbcan.2009.11.002. View

4.
Altschuler S, Wu L . Cellular heterogeneity: do differences make a difference?. Cell. 2010; 141(4):559-63. PMC: 2918286. DOI: 10.1016/j.cell.2010.04.033. View

5.
Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View